HALO
Halozyme Therapeutics, Inc. · Healthcare · Biotechnology
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 132 | -2 | 91.18M | $6.60B | +5 | −6 |
| Q1 2026 | 136 | +1 | 88.77M | $5.36B | +7 | −7 |
| Q4 2025 | 135 | -1 | 97.38M | $6.16B | +1 | −1 |
| Q3 2025 | 22 | +1 | 49.86M | $3.66B | +1 | −1 |
| Q2 2025 | 19 | 0 | 43.24M | $2.25B | — | — |
| Q1 2025 | 16 | -1 | 15.61M | $996.39M | — | −1 |
| Q4 2024 | 17 | +3 | 17.59M | $840.95M | +4 | −1 |
| Q3 2024 | 13 | -1 | 6.97M | $398.81M | — | −1 |
| Q2 2024 | 14 | — | 8.14M | $426.06M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasif) | 3.03M | — | $158.64M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasif) | 3.03M | — | $158.64M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.30M | — | $68.16M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.30M | — | $68.16M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Norges Bank ✦ (pasif) | 1.22M | — | $63.68M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 478.77K | — | $25.07M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Millennium Management ✦ | 423.19K | — | $22.16M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Millennium Management ✦ | 423.19K | — | $22.16M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 397.78K | — | $20.83M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 397.78K | — | $20.83M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 397.78K | — | $20.83M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 397.78K | — | $20.83M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 397.78K | — | $20.83M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 377.58K | — | $19.77M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 347.70K | — | $18.21M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 347.70K | — | $18.21M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 347.70K | — | $18.21M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 303.28K | — | $15.88M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Arrowstreet Capital ✦ | 102.75K | — | $5.38M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 48.99K | — | $2.56M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 47.77K | — | $2.50M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 47.77K | — | $2.50M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 47.77K | — | $2.50M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Bridgewater Associates ✦ | 33.22K | — | $1.74M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Gotham Asset Management ✦ | 28.38K | — | $1.49M | 0.0% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 8 pemegang, 32.79M saham, $43.93M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer, Director · 9.60K lbr · $1.03M
Officer, Director · 3.20K lbr · $344,848
Officer, Director · 7.20K lbr · $765,778
Officer, Director · 5.70K lbr · $587,882
Officer, Director · 9.40K lbr · $985,816
Officer, Director · 4.90K lbr · $509,827
Officer, Director · 900 lbr · $89,062
Officer, Director · 500 lbr · $50,228
Officer, Director · 2.10K lbr · $213,709
Officer, Director · 9.00K lbr · $922,977
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi